Hormonal
Dietary intake of non-starch polysaccharides (NSPs), particularly soluble types like mixed-link β-glucans, lowers plasma cholesterol and normalizes blood glucose and insulin levels, thereby reducing the risk of cardiovascular disease and Type 2 diabetes.
To support heart health and blood sugar control, prioritize foods rich in soluble fiber, such as oats, barley, and beans. These foods help lower cholesterol and stabilize blood glucose. You do not need to measure exact doses; simply incorporating these foods into your regular diet is the recommended approach.
soluble NSPs (especially mixed-link β-glucans) lower plasma cholesterol levels and help to normalize blood glucose and insulin levels, making these kinds of polysaccharides a part of dietary plans to treat cardiovascular diseases and Type 2 diabetes.
Why this rating
This is a review paper summarizing various studies; it cites specific effects but does not present new primary clinical trial data itself.
Source
Dietary Roles of Non-Starch Polysachharides in Human Nutrition: A Review
Vikas Kumar et al. · Critical Reviews in Food Science and Nutrition · 2012
DOI 10.1080/10408398.2010.512671
More from this paper
- Insoluble non-starch polysaccharides (specifically cellulose and hemicellulose) act as effective laxatives by providing bulk to gut contents, promoting normal laxation and preventing constipation.Moderate
- Fermentation of non-starch polysaccharides by colonic microflora produces short-chain fatty acids (SCFAs), particularly butyrate, which promotes large bowel health, inhibits pathogenic organisms, and may offer a prebiotic effect.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →